The GOOD Guide to Cannabis
Welcome to the golden age of marijuana. Indeed, the future is dope.
- Most Read
Pregnant woman hilariously shuts down man who refused to give up his seat for her.by Molly Mulshine
What Americans say vs. what they mean.by Bronwyn Isaac
3 things women say that weaken the power of their words.by GOOD Staff
People are dying over this kid's emotional reaction to learning his sister is his half-sisterby GOOD Staff
Willie Nelson has three words for country fans who can’t stand that he’s supporting a Democrat.by Tod Perry
To the red-haired girl at the splash pad who asked about my daughter with down syndrome.by The Mighty, Michelle Odland
20 years ago, a doctor published a study. It was completely made up, and it made us all sicker.by GOOD Staff
NASA’s List Of The Best Air-Filtering Houseplantsby Tod Perry
Six siblings appeared in this campaign ad to endorse their brother’s opponent.by Eric Pfeiffer
Investment Tips From “The Wolf Of Weed Street”
by Max Cherney
State legalization has unsurprisingly proved a boon to the cannabis business: Legal marijuana sales in the United States are projected to reach $7.1 billion this year, and some analysts are calling weed the country’s fastest-growing industry. Still, the plant’s pesky status as a Schedule I illegal substance—heroin is federally regulated the same way—makes cannabis a risky investment. Most publicly traded, marijuana-based businesses remain wild penny stocks, but there’s a reason to be optimistic.
For one, the legal market is growing. Cannabis is recreationally legal in four states and medically in 25 states (up to 12 states could vote on legalization measures this November). Meanwhile, biopharmaceutical companies are ramping up research with the support of the federal government. The Democratic Party even wrote federal rescheduling—the potential of reclassifying cannabis—into its 2016 national platform.
Currently, the Marijuana Index series, an equity tracker for marijuana stocks, puts the U.S. market cap for publicly traded cannabis companies at just under $5 billion. This includes, yes, a handful of companies trading on the Nasdaq Stock Market—mostly drug discovery firms, but also an innovative pill-making business and an industrial hemp manufacturer. MassRoots, a cannabis-themed social network, was rejected by the exchange this May.
Investment Tips from the “Wolf of Weed Street”
Jason Spatafora, the self proclaimed “Wolf of Weed Street,” runs MarijuanaStocks.com, the leading hub for cannabis stock news, trends, and insights. Here, the Wolf offers tips for aspiring marijuana moguls.
Pay Attention to Politics: Pot stocks often move because of regulatory action, so keep an eye on legislative measure and federal agencies.
Don’t Buy Into Hype: Invest in companies that are actually doing something, not just hawking theoretical products.
Look for Opportunities in Biotech: If the Drug Enforcement Administration reschedules cannabis, Big Pharma will embrace it and make pharmaceutical efforts look cheap.
Lock in Gains Quickly: Irrational exuberance is the name of the game.
Illustrations by Emily Lin